PRECINCT PARTNERS

QIMR Berghofer Medical Research Institute

QIMR Berghofer Medical Research Institute is a world leader of research in cancer, infection and inflammation, brain and mental health and population health.  The Institute’s purpose is to deliver better health and wellbeing through impactful medical research, which is done by developing new diagnostics, better treatments and more effective strategies to prevent diseases affecting people here in Queensland and globally.  These include heart disease, dementia, asthma, liver disease, mental health conditions and many types of cancer.

The Institute is internationally recognised for work on immunotherapy, genomics, skin cancer, mosquito-borne diseases, tropical diseases and genetic risk factors associated with cancers and mental health disorders.

Established in 1945, QIMR Berghofer is now home to almost 1,000 scientists, students and support staff in more than 60 state-of-the-art laboratories.

QIMR Berghofer’s cutting edge facilities include:

  • Q-Gen Cell Therapeutics – a fully integrated facility for translational research within QIMR Berghofer manufacturing cell-based therapies and translating QIMR Berghofer’s clinical research to the bedside
  • an insectary – the largest of its kind in the southern hemisphere and one of the largest in the world – to support research into mosquito control and mosquito-borne diseases
  • integrated scientific services, including NATA accredited histology, flow cytometry and imaging, as well as proteomics, sample processing, analytical services, DNA sequencing and genome informatics.

To fast-track progression of research discoveries to the clinic, the Institute has also founded two spinout companies. Cyteph is focused on developing off-the-shelf cell therapies to treat brain cancer, while Fovero Therapeutics is pioneering a new class of immunotherapy for difficult-to-treat cancers.

QIMR Berghofer produces about 600 research papers a year, with more than 60 per cent having an international research collaborator named as an author. This research is at the forefront of health advances for the benefit of humanity. The Institute’s development of a drug called NACE2i, which has demonstrated potential in protecting against all SARS-CoV-2 variants and alleviating persistent inflammation associated with long COVID, is just one example of its incredible reach.

QIMR Berghofer Medical Research Institute

www.qimrberghofer.edu.au